Ryan Pardo
Known title: See RemarksCIK: 0001865531
Associated companies
Transaction History
| LFST | ▼ Sell | Tax Withholding | 9,376 | $60K | 4/1/2026 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 12,280 | $85K | 3/9/2026 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 15,841 | $109K | 3/9/2026 | View on chart |
| LFST | ▲ Buy | Grant | 105,711 | $0 | 3/9/2026 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 38,479 | $266K | 3/9/2026 | View on chart |
| LFST | ▲ Buy | Grant | 40,254 | $0 | 3/9/2026 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 21,854 | $151K | 3/6/2026 | View on chart |
| LFST | ▲ Buy | Grant | 129,496 | $0 | 3/5/2026 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 9,377 | $62K | 4/1/2025 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 12,280 | $87K | 3/10/2025 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 13,671 | $104K | 3/7/2025 | View on chart |
| LFST | ▲ Buy | Grant | 41,609 | $0 | 3/7/2025 | View on chart |
| LFST | ▲ Buy | Grant | 95,875 | $0 | 3/7/2025 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 28,154 | $214K | 3/7/2025 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 18,919 | $149K | 3/6/2025 | View on chart |
| LFST | ▲ Buy | Grant | 114,213 | $0 | 3/6/2025 | View on chart |
| LFST | ▼ Sell | Open Market | 61,508 | $332K | 6/12/2024 | View on chart |
| LFST | ▼ Sell | Open Market | 9,830 | $58K | 4/1/2024 | View on chart |
| LFST | ▼ Sell | Open Market | 39,384 | $249K | 3/14/2024 | View on chart |
| LFST | ▲ Buy | Grant | 124,826 | $0 | 3/8/2024 | View on chart |
| LFST | ▲ Buy | Grant | 95,874 | $0 | 3/8/2024 | View on chart |
| LFST | ▼ Sell | Open Market | 50,136 | $447K | 6/26/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 6,398 | $49K | 4/4/2023 | View on chart |
| LFST | ▲ Buy | Grant | 192,307 | $0 | 3/6/2023 | View on chart |
| LFST | ▼ Sell | Open Market | 56,370 | $302K | 6/13/2022 | View on chart |
| LFST | ▲ Buy | Grant | 95,311 | $0 | 4/25/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Keybanc Raises LifeStance Health Price Target to $15
Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.
Keybanc Raises LifeStance Health Price Target to $15. Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.